H35.141 Retinopathy of prematurity, stage 3, right eye

Name of the Condition

• Retinopathy of prematurity, stage 3, right eye

Summary

Retinopathy of prematurity (ROP) is a disorder affecting premature infants, characterized by abnormal blood vessel development in the retina. Stage 3 represents a more advanced phase where abnormal blood vessels grow and partially detach the retina. This stage carries a higher risk of progression to severe vision loss if untreated, requiring prompt evaluation and intervention. The right eye is specifically affected in this diagnosis.

Causes

ROP is caused by the incomplete growth of retinal blood vessels in premature infants. The retina, which normally develops blood vessels by full-term birth, may not have fully vascularized in preterm infants. Factors such as oxygen therapy, fluctuations in oxygen levels, and the infant's overall immaturity contribute to abnormal vessel growth, with stage 3 reflecting significant retinal changes.

Risk Factors

• Prematurity (especially infants born before 31 weeks of gestation).
• Low birth weight (typically under 1500 grams).
• Oxygen therapy or fluctuations in oxygen levels during neonatal care.
• Multiple births (e.g., twins or triplets).
• Certain medical conditions affecting oxygen delivery or retinal development.

Symptoms

In stage 3, ROP may not present obvious symptoms in infants. Severe cases can lead to abnormal eye movements, a white appearance of the pupil (leukocoria), or vision impairment as the child grows. Infants with ROP are typically asymptomatic, and diagnosis relies on routine screening.

Diagnosis

Diagnosis is made through a comprehensive eye examination, typically performed by an ophthalmologist specializing in retinal disorders. The exam assesses retinal blood vessel development, detachment, and stage progression. Imaging or specialized equipment may be used to evaluate the extent of retinal involvement.

Treatment Options

Treatment depends on the severity and progression of the condition. Options may include laser therapy, cryotherapy, or anti-VEGF injections to halt abnormal blood vessel growth. Close monitoring is essential to determine the need for intervention.

Prognosis and Follow-Up

Prognosis varies based on the stage and response to treatment. Stage 3 ROP requires ongoing follow-up to monitor for regression or progression. Long-term vision outcomes depend on timely intervention and the infant's overall health.

Complications

Untreated stage 3 ROP can lead to retinal detachment, permanent vision loss, or blindness. Other complications may include myopia, strabismus, or amblyopia.

Lifestyle & Prevention

Prevention focuses on managing risk factors, such as optimizing oxygen therapy and supporting premature infant development. Regular eye screenings for at-risk infants are critical for early detection.

When to Seek Professional Help

Seek immediate medical attention if signs of severe ROP are observed, such as leukocoria, abnormal eye movements, or vision changes. Routine screenings are essential for at-risk infants.

Tips for Medical Coders

Document the specific eye (right) and stage (3) clearly. Ensure the diagnosis aligns with clinical findings and screening results. Code H35.141 is used when the right eye is affected; specify laterality and stage accurately.